Discover the data behind diagnostic variability and why we believe biomarkers, including oculomotor ones, could be part of the way forward.

Discover the reliability of oculomotor biomarkers and how consistent eye movement metrics support early detection of neurological disorders

Learn more about how neuroClues® eye movement biomarkers could support early detection of cognitive impairments.

Learn more about the differences between voluntary and reflexive saccades, the structures involved in those movements, and how they can provide interesting clues about brain health.

Learn more about neuroClues®’ role in the ICEBERG cohort with 50 patients recorded, and how eye movement analysis is advancing cognitive impairment detection.

Explore how neuroClues calculates the reference oculomotor ranges in eye tracking, with exclusive insights into the technical details.

Explore recent studies on how eye movements can support pharmaceutical research in diagnosing, monitoring, and developing new neurological treatments.

The newsletter of this month will emphasize the latest research about Multiple Sclerosis

The newsletter of this month will emphasize the latest research about Alzheimer’s Disease